Two previous studies by Colebatch and Lefevre et al.[43,44] have suggested that MAP CRCs can also develop through a MSI pathway (by inactivation of MLH1) because of the finding of MSI-high phenotype in one out of three and one out of six MAP CRCs, respectively. This evidence concerns the gene MLH1 and familial adenomatous polyposis 2.